Balanced news tone
News Sentiment
JAGSNPHARM sentiment intelligence
Jagsonpal Pharmaceuticals Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
74/100 classification confidence.
directly relevant articles
high-authority source matches
-1.6% over one week, +10.1% over four weeks, trend active, and near fair-value range.
Jagsonpal Pharma rallies 14% on acquisition update; time to book profit?
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Jagsonpal Pharma rallies 14% on acquisition update; time to book profit?
- Tone
- Positive 66/100
- Event
- Deals and strategy
- Published
- 30 Jun 2026 07:00
- Source
- Business Standard
Jagsonpal to acquire 85% stake in Aequitas for ₹20.8 crore
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 29 Jun 2026 07:00
- Source
- scanx.trade
Jagsonpal Pharmaceuticals extinguishes 16 lakh shares
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jun 2026 07:00
- Source
- scanx.trade
Jagsonpal concludes ₹40 crore buyback at ₹250 per share
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 25 May 2026 07:00
- Source
- scanx.trade
Hikma Pharmaceuticals PLC stock (GB00B128J450): Dividend hike and $250M buyback
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 11 May 2026 07:00
- Source
- ad-hoc-news.de
Jagsonpal Buyback Opens May 8, 2026; Letter of Offer Dispatched
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 06 May 2026 07:00
- Source
- scanx.trade
Jagsonpal Pharmaceuticals Q4 FY26: 200% Dividend, INR40 Crore Buyback
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 04 May 2026 07:00
- Source
- scanx.trade
Jagsonpal Pharmaceuticals Publishes Postal Ballot Notice for ₹40 Crore Buyback
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 26 Mar 2026 07:00
- Source
- scanx.trade
Jagsonpal Pharma surges 12% after buyback plan of up to 16 lakh shares at ₹250 each
- Tone
- Positive 66/100
- Event
- Capital return
- Published
- 12 Mar 2026 07:00
- Source
- CNBC TV18
Jagsonpal Pharmaceuticals To Consider Share Buyback
- Tone
- Positive 62/100
- Event
- Capital return
- Published
- 09 Mar 2026 07:00
- Source
- TradingView
We Think Shareholders Should Be Aware Of Some Factors Beyond Jagsonpal Pharmaceuticals' (NSE:JAGSNPHARM) Profit
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 13 Nov 2025 08:00
- Source
- simplywall.st
We Take A Look At Why Jagsonpal Pharmaceuticals Limited's (NSE:JAGSNPHARM) CEO Compensation Is Well Earned
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Sep 2025 07:00
- Source
- simplywall.st
Market Might Still Lack Some Conviction On Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM) Even After 33% Share Price Boost
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Jul 2025 07:00
- Source
- simplywall.st
Jagsonpal Pharmaceuticals 1:2.5 stock split record date tomorrow. Do you own?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 07 Jan 2025 08:00
- Source
- The Economic Times
Jagsonpal Pharmaceuticals Ltd. Share Price Today | Jagsonpal Pharma Live NSE/BSE
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Mar 2022 19:13
- Source
- Value Research
Convergent Funds to buy stake in Jagsonpal Pharmaceuticals in first control bet
- Tone
- Positive 66/100
- Event
- Deals and strategy
- Published
- 21 Feb 2022 08:00
- Source
- VCCircle
Funds advised by Convergent Finance LLP to acquire a controlling stake in Jagsonpal Pharmaceuticals Limited
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 21 Feb 2022 08:00
- Source
- Business Standard